Headache recurrence with sumatriptan fast disintegrating tablets: results from two double-blind, placebo-controlled trials

被引:0
|
作者
Dahlof, C
Taylor, FR
Mulleners, W
Adelman, J
Webster, C
Few, C
机构
[1] Gothenburg Migraine Clin, Gothenburg, Sweden
[2] Pk Nicollet Hlth Serv, Minneapolis, MN USA
[3] Canisius Wilhelmina Hosp, Nijmegen, Netherlands
[4] Headache Wellness Ctr, Greensboro, NC USA
[5] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
关键词
sumatriptan; fast disintegrating; migraine; recurrence;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:927 / 927
页数:1
相关论文
共 50 条
  • [1] Sustained pain relief and sustained pain-free rates with sumatriptan fast disintegrating tablets: results from two double-blind, placebo-controlled trials
    Dahlof, C
    Taylor, FR
    Mulleners, W
    Adelman, J
    Webster, C
    Few, C
    CEPHALALGIA, 2005, 25 (10) : 927 - 928
  • [2] Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets
    Sheftell, FD
    Dahlöf, CGH
    Brandes, JL
    Agosti, R
    Jones, MW
    Barrett, PS
    CLINICAL THERAPEUTICS, 2005, 27 (04) : 407 - 417
  • [3] Eletriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan
    Goadsby, PJ
    Ferrari, MD
    Olesen, J
    Stovner, LJ
    Senard, JM
    Jackson, NC
    Poole, PH
    NEUROLOGY, 2000, 54 (01) : 156 - 163
  • [4] Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: A randomized, double-blind, placebo-controlled study
    Ishkanian, Gary
    Blumenthal, Harvey
    Webster, Christopher J.
    Richardson, Mary S.
    Ames, Michael
    CLINICAL THERAPEUTICS, 2007, 29 (01) : 99 - 109
  • [5] Sumatriptan-Naproxen and Butalbital: A Double-Blind, Placebo-Controlled Crossover Study
    Derosier, Frederick
    Sheftell, Fred
    Silberstein, Stephen
    Cady, Roger
    Ruoff, Gary
    Krishen, Alok
    Peykamian, Margaret
    HEADACHE, 2012, 52 (04): : 530 - 543
  • [6] A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER STUDY OF SUBCUTANEOUS SUMATRIPTAN IN GENERAL-PRACTICE
    RUSSELL, MB
    HOLMTHOMSEN, OE
    NIELSEN, MR
    CLEAL, A
    PILGRIM, AJ
    OLESEN, J
    CEPHALALGIA, 1994, 14 (04) : 291 - 296
  • [7] Sumatriptan nasal spray in adolescent migraineurs: A randomized, double-blind, placebo-controlled, acute study
    Winner, P
    Rothner, AD
    Wooten, JD
    Webster, C
    Ames, M
    HEADACHE, 2006, 46 (02): : 212 - 222
  • [8] Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: Results of a multicenter, randomized, placebo-controlled study
    Carpay, J
    Schoenen, J
    Ahmad, F
    Kinrade, F
    Boswell, D
    CLINICAL THERAPEUTICS, 2004, 26 (02) : 214 - 223
  • [9] Atypical facial pain: A double-blind placebo-controlled crossover pilot study of subcutaneous sumatriptan.
    Harrison, SD
    Balawi, SA
    Feinmann, C
    Harris, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1997, 7 (02) : 83 - 88
  • [10] A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents
    Winner, P
    Rothner, AD
    Saper, J
    Nett, R
    Asgharnejad, M
    Laurenza, A
    Austin, R
    Peykamian, M
    PEDIATRICS, 2000, 106 (05) : 989 - 997